The Proteomics Shared Resource (Proteomics SR) is an essential asset to Case Comprehensive Cancer Center (Case CCC) members' research, illustrated by the breadth of scientific program involvement and reflected in the large number of investigators who use this SR. Last year alone, over 120 investigators, 35% of whom were Case CCC members, accounting for 44% of total usage, from all 7 of the Case CCC Programs used the SR. The mission of the Proteomics SR is to provide advanced proteomic and metabolomic technologies and small- molecule analysis, especially for pharmacokinetic (PK) studies, via state-of-the-art instruments, computational resources, and trained staff, to support clinical, translational, and structural biology research.
The Specific Aims of the Proteomics SR are to: 1) Provide advanced proteomic and metabolomics technologies and instrument resources to solve unmet needs in cancer research. 2) Develop and apply systems biology tools to solve challenges in analysis and integration of large ?omics? datasets. 3) Provide professional education, consultation and training to Case CCC members. At last review, the Proteomics SR was rated Exceptional merit. Throughout the current funding cycle (2012- 2016), the Proteomics SR provided services to 268 registered users, 83 (31%) of whom are Case CCC members, representing all 7 of the Case CCC programs. The Proteomics SR continues to attract new users, and to provide multiple sophisticated proteomic techniques and technique-specific training to investigators' cancer-related projects. The SR has also developed new technologies and bioinformatics tools that directly facilitate Case CCC members' research, including a global metabolomic and lipidomic platform that will complement both targeted metabolomics and global proteomic experiments. The Proteomics SR consists of two sites; the first site was established at the Cleveland Clinic (CC) Lerner Research Institute (LRI) in 1999 and the second site, the Center for Proteomics & Bioinformatics (CPB) at Case Western Reserve University (CWRU) in 2005. This multi-site Shared Resource, jointly supported and managed by the Case CCC, the CWRU School of Medicine (SOM) and CC, provides access to a full spectrum of proteomic and metabolomic technologies. The services of the Proteomics SR are essential for enhancing the quality of the science in the Case Comprehensive Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-30
Application #
9904146
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
30
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Augestad, Knut M; Keller, Deborah S; Bakaki, Paul M et al. (2018) The impact of rectal cancer tumor height on recurrence rates and metastatic location: A competing risk analysis of a national database. Cancer Epidemiol 53:56-64
Chen, Lechuang; Feng, Zhimin; Yue, Hong et al. (2018) Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun 9:4585
Patel, Rutulkumar; Zhang, Luchang; Desai, Amar et al. (2018) Mlh1 deficiency increases the risk of hematopoietic malignancy after simulated space radiation exposure. Leukemia :
Lager, Angela M; Corradin, Olivia G; Cregg, Jared M et al. (2018) Rapid functional genetics of the oligodendrocyte lineage using pluripotent stem cells. Nat Commun 9:3708
Patel, Rutulkumar; Qing, Yulan; Kennedy, Lucy et al. (2018) MMR Deficiency Does Not Sensitize or Compromise the Function of Hematopoietic Stem Cells to Low and High LET Radiation. Stem Cells Transl Med 7:513-520
Desai, Amar; Zhang, Yongyou; Park, Youngsoo et al. (2018) A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support. Haematologica 103:1054-1064
Cummings III, Kenneth C; Zimmerman, Nicole M; Maheshwari, Kamal et al. (2018) Epidural compared with non-epidural analgesia and cardiopulmonary complications after colectomy: A retrospective cohort study of 20,880 patients using a national quality database. J Clin Anesth 47:12-18
Thiagarajan, Praveena S; Sinyuk, Maksim; Turaga, Soumya M et al. (2018) Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase. Nat Commun 9:578
Qiu, Zhaojun; Oleinick, Nancy L; Zhang, Junran (2018) ATR/CHK1 inhibitors and cancer therapy. Radiother Oncol 126:450-464
Elitt, Matthew S; Shick, H Elizabeth; Madhavan, Mayur et al. (2018) Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease. Stem Cell Reports 11:711-726

Showing the most recent 10 out of 1227 publications